Source: Anti-Cancer Drugs. Unidades: FMRP, FFCLRP
Subjects: ANTINEOPLÁSICOS (DESENVOLVIMENTO), CITOTOXINAS, OSTEOSSARCOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOGADO, Rodrigo F. E. et al. Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments. Anti-Cancer Drugs, v. 26, n. 1, p. 56-63, 2015Tradução . . Disponível em: https://doi.org/10.1097/CAD.0000000000000157. Acesso em: 04 ago. 2024.APA
Bogado, R. F. E., Pezuk, J. A., Oliveira, H. F. de, Tone, L. G., & Brassesco, M. S. (2015). Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments. Anti-Cancer Drugs, 26( 1), 56-63. doi:10.1097/CAD.0000000000000157NLM
Bogado RFE, Pezuk JA, Oliveira HF de, Tone LG, Brassesco MS. Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments [Internet]. Anti-Cancer Drugs. 2015 ; 26( 1): 56-63.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1097/CAD.0000000000000157Vancouver
Bogado RFE, Pezuk JA, Oliveira HF de, Tone LG, Brassesco MS. Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments [Internet]. Anti-Cancer Drugs. 2015 ; 26( 1): 56-63.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1097/CAD.0000000000000157
